US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on:

1. The PD-L1 biomarker and its role in immunotherapy - time in video 00:50
2. Development of an FDA-approved IHC diagnostic assay - time in video 02:26
3. How to manage tissue heterogeneity - time in video 08:04
4. PD-L1 assay in clinical trial - time in video 09:14

For questions, comments, or study ideas please contact your U.S. medical and scientific affairs managers or email us at: [email protected]

TE-US-00016